Stocks TelegraphStocks Telegraph
Stock Ideas

SRTS Stock Performance and Key Statistics

NASDAQ : SRTS

Sensus Healthcare

$3.08
0.03+0.98%
At Close 4:00 PM
64.62
B-ESG ScoreESG Rating

stock performance chart

SRTS Fundamental Analysis

Based on recent data, Sensus Healthcare, Inc. (SRTS) shows an Average True Range (ATR) of 0.28 and an Enterprise Value of 31.41M. Its average trading volume over the past 3 months is 61.59K, indicating liquidity. These fundamental metrics provide insight into SRTS's underlying financial health and market activity.

ATR0.28
Enterprise Value31.41M
Avg Vol (3 Months)61.59K
Avg Vol (10 Days)26.15K

SRTS Technical Analysis Indicators

Sensus Healthcare, Inc. (SRTS) technical indicators as of July 14, 2026: the SMA 20 is -10.34%, SMA 50 at -9.43%, and SMA 200 at -2.85%. The RSI 14 value is 39.39, suggesting its current momentum. These technical analysis signals help assess SRTS's price trends and potential future movements.

SMA 20-10.34%
SMA 50-9.43%
SMA 200-2.85%
RSI 1439.39

SRTS Stock Performance Overview

Sensus Healthcare, Inc. (SRTS) stock performance overview as of July 14, 2026: The 52-week high is $5.92 (currently -32.09% below), and the 52-week low is $2.66 (currently 32.67% above). Over the past year, SRTS's performance is -26.3%, compared to the S&P 500's 5.51% change.

52-Week High5.92
52-Week High Chg-32.09%
52-Week Low2.66
52-Week Low Chg+32.67%
S&P 500 52-Week Chg5.51%

Sensus Healthcare, Inc. (SRTS) Historical Stock Performance

According to market data, Sensus Healthcare, Inc. (SRTS) stock's recent performance metrics show that over the last month, SRTS is 31.56%, with a Year-to-Date (YTD) performance of 24.62%. Over the past year, the stock has seen a -26.3% change. These figures summarize SRTS's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High3.243.244.555.495.925.49
Low2.922.662.662.662.662.66
Performance+7.59%+31.56%+55.00%+7.83%-26.30%+24.62%

Industry Analysis and Valuation

According to current financial data, SRTS stock's P/E (TTM) ratio is -6.73, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for SRTS, including P/S (2.32), P/B (1.15), and P/FCF (-70.52), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationSRTSSector MedianIndustry AvgS&P 500
P/E (TTM)-6.73-1.22-27.132.59
P/S (TTM)2.323.6914.855.98
P/B (TTM)1.1526.035.895.29
P/FCF (TTM)-70.52-5.16-2.729.92

Frequently Asked Questions

How is SRTS price-to-earnings ratio currently?
SRTS has a current P/E ratio of -6.73
How are SRTS's price-to-sale and price-to-book ratios?
The SRTS stock has a trailing twelve month price-to sales (P/S) ratio of 2.32 while its price-to-book (P/B) value is 1.15.
Is Sensus Healthcare, Inc.'s price-to-cashflow ratio high or low?
SRTS's price-to-free-cashflow (P/FCF) ratio is -70.52, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for SRTS?
Based on SRTS's recent bid, its distance from 20 days simple moving average is -10.34%. It is -9.43% apart from 50 days simple moving average, and it is -2.85% apart from 200 days simple moving average.
What is the 52-week price range for SRTS?
The 52-week high for SRTS is $5.92 which is -32.09% away from the current price level whereas the distance of that from the 52-week low of $2.66 stands at 32.67%.
An overview of SRTS's stock performance: how did it fare?
The performance of SRTS stock was not encouraging with most of its significant price indicators in green. Sensus Healthcare, Inc.(NASDAQ: SRTS) shares have moved upward +0.98% or $0.03 in the latest trading session and have gained 24.62% year-to-date (YTD). The stock has lost nearly -26.3% over the past year. After moving 55% over the trailing 3-month period, the stock is 7.83% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 7.59% a week and 31.56% a month.
What is SRTS's 14-day relative strength index (RSI)?
The current 14-day RSI for SRTS stock is 39.39. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For SRTS, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Sensus Healthcare, Inc. (SRTS) has a 14-day ATR of 0.28.
What is SRTS's current enterprise value?
After closing at $3.05 with 16.46M of its shares outstanding, the current enterprise value of SRTS is roughly 31.41M.
Over the past year, how has the stock price of SRTS changed?
Sensus Healthcare, Inc. (NASDAQ: SRTS) is down -26.3% when it comes to the percentage price change over the past 52-weeks. The percentage price change came less than that of broader S&P 500 index that came at a fall of 5.51%. SRTS stock price is also up 24.62% on its value in year-to-date trading.
What is the average trading volume for SRTS shares?
The number outstanding shares of SRTS is 16.46M, and of these 84.29% shares are freely available for trading. On average, SRTS stock has traded 26.15K shares per day for the past 10 days. A total of 44.8K shares changed hands during the last trading session with the average session volume of 60.59K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph